InsiderTrades

Form 4 for TNDM TANDEM DIABETES CARE INC

Accepted 2021-09-09 00:00:00 ET · period of report 2021-09-07 · accession 0001438133-21-000163 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2021-09-09 2021-09-07 TNDM Leal James SVP, Ops M - OptEx $82.34 +3,574 7,325 +95% +$294.3K
D 2021-09-09 2021-09-07 TNDM Leal James SVP, Ops S - Sale+OE $123.00 -3,574 3,751 -49% -$439.6K
D 2021-09-09 2021-09-07 TNDM Leal James SVP, Ops M - OptEx $82.34 +3,574 7,862 +83% +$294.3K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-09-07 M A 3,574 $82.34 7,325 D — —
2 Common Common Stock 2021-09-07 S D 3,574 $123.00 3,751 D — —
3 Derivative Stock Option 2021-09-07 M A 3,574 $82.34 7,862 D $82.34 · — to — 3,574 Common Stock (F3) The options vested as to twenty-five (25%) of the underlying shares on 5/27/2021, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter, subject to the terms of Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan"). (F4) The expiration date for these options is 10 years from the date of grant.